Idexx Laboratories (IDXX) Total Non-Current Liabilities (2009 - 2026)

Idexx Laboratories' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $529.5 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 15.87% year-over-year to $529.5 million; the TTM figure through Mar 2026 stood at $529.5 million (down 15.87% YoY), while the FY2025 annual figure was $596.6 million, down 5.34% from the prior year.
• Total Non-Current Liabilities was $529.5 million for Q1 2026 at Idexx Laboratories, down from $596.6 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $983.6 million in Q2 2022 to a low of $529.5 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $773.9 million across 5 years, with a median of $818.8 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities retreated 2.17% in 2022, then retreated 23.95% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $902.2 million in 2022, then dropped by 8.69% to $823.8 million in 2023, then dropped by 23.5% to $630.2 million in 2024, then fell by 5.34% to $596.6 million in 2025, then fell by 11.23% to $529.5 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $529.5 million (Q1 2026), $596.6 million (Q4 2025), and $573.7 million (Q3 2025), per Business Quant data.